Visioneering Technologies, Inc. (VTI.AX)
- Previous Close
0.1450 - Open
0.1600 - Bid 0.1200 x 253536800
- Ask 0.1400 x 258966100
- Day's Range
0.1200 - 0.1600 - 52 Week Range
0.1200 - 0.4200 - Volume
138,793 - Avg. Volume
17,488 - Market Cap (intraday)
7.482M - Beta (5Y Monthly) 1.65
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1500 - Earnings Date Apr 23, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal one-day contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.
www.vtivision.comRecent News: VTI.AX
Performance Overview: VTI.AX
Trailing total returns as of 4/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VTI.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VTI.AX
Valuation Measures
Market Cap
7.48M
Enterprise Value
4.24M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.35
Price/Book (mrq)
0.84
Enterprise Value/Revenue
0.49
Enterprise Value/EBITDA
-1.26
Financial Highlights
Profitability and Income Statement
Profit Margin
-39.80%
Return on Assets (ttm)
-29.77%
Return on Equity (ttm)
-57.27%
Revenue (ttm)
8.67M
Net Income Avi to Common (ttm)
-3.45M
Diluted EPS (ttm)
-0.1500
Balance Sheet and Cash Flow
Total Cash (mrq)
3M
Total Debt/Equity (mrq)
3.70%
Levered Free Cash Flow (ttm)
-2.64M
Research Analysis: VTI.AX
Company Insights: VTI.AX
VTI.AX does not have Company Insights